UnitedHealth Group Incorporated $UNH Shares Sold by Associated Banc Corp

Associated Banc Corp trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 54,264 shares of the healthcare conglomerate’s stock after selling 1,999 shares during the period. Associated Banc Corp’s holdings in UnitedHealth Group were worth $16,929,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. HHM Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 0.9% during the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after purchasing an additional 26 shares during the period. Hemington Wealth Management boosted its holdings in shares of UnitedHealth Group by 2.5% during the first quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after acquiring an additional 28 shares during the period. Tlwm increased its holdings in shares of UnitedHealth Group by 1.0% in the 1st quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,433,000 after acquiring an additional 28 shares during the period. Evermay Wealth Management LLC boosted its stake in UnitedHealth Group by 1.2% during the 1st quarter. Evermay Wealth Management LLC now owns 2,413 shares of the healthcare conglomerate’s stock valued at $1,264,000 after purchasing an additional 29 shares during the period. Finally, MGO One Seven LLC raised its holdings in shares of UnitedHealth Group by 0.3% during the first quarter. MGO One Seven LLC now owns 8,781 shares of the healthcare conglomerate’s stock valued at $4,599,000 after buying an additional 30 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Oppenheimer lowered their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Royal Bank Of Canada upped their price objective on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Barclays raised their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Truist Financial increased their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Finally, Robert W. Baird restated an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Trading Down 0.3%

Shares of UNH opened at $318.89 on Tuesday. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $622.83. The stock has a market capitalization of $288.86 billion, a P/E ratio of 16.64, a P/E/G ratio of 2.28 and a beta of 0.47. The business’s 50-day moving average price is $344.10 and its 200 day moving average price is $315.39.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the business earned $7.15 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.